Pharmaceuticals 2009, 2(3), 206-216; doi:10.3390/ph2030206
Review

Interferons as Therapy for Viral and Neoplastic Diseases: From Panacea to Pariah to Paragon

* email and email
Received: 13 November 2009; in revised form: 2 December 2009 / Accepted: 7 December 2009 / Published: 15 December 2009
(This article belongs to the Special Issue Interferons)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: For more than 20 years after the excitement engendered by their discovery in 1957 as antiviral agents, there were no significant clinical uses of interferons; however, following their cloning they have been employed as effective treatment for several viral, autoimmune, and neoplastic diseases.
Keywords: interferon; clinical applications; cancer; infectious diseases; multiple sclerosis
PDF Full-text Download PDF Full-Text [164 KB, uploaded 15 December 2009 10:36 CET]

Export to BibTeX |
EndNote


MDPI and ACS Style

Friedman, R.M.; Contente, S. Interferons as Therapy for Viral and Neoplastic Diseases: From Panacea to Pariah to Paragon. Pharmaceuticals 2009, 2, 206-216.

AMA Style

Friedman RM, Contente S. Interferons as Therapy for Viral and Neoplastic Diseases: From Panacea to Pariah to Paragon. Pharmaceuticals. 2009; 2(3):206-216.

Chicago/Turabian Style

Friedman, Robert M.; Contente, Sara. 2009. "Interferons as Therapy for Viral and Neoplastic Diseases: From Panacea to Pariah to Paragon." Pharmaceuticals 2, no. 3: 206-216.

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert